Understanding Wnt signaling through Ror and Ryk family receptor tyrosine kinases

了解通过 Ror 和 Ryk 家族受体酪氨酸激酶的 Wnt 信号传导

基本信息

  • 批准号:
    9244390
  • 负责人:
  • 金额:
    $ 53.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-05-01 至 2017-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The goal of this proposal is to understand how two receptor tyrosine kinases (RTKs) with Wnt-binding domains in their extracellular regions mediate and/or contribute to Wnt signaling. Wnts are secreted ligands of approximately 330 amino acids that play key roles in embryonic development and control a spectrum of processes in the adult, ranging from organ regeneration to stem cell maintenance to neural circuit generation to sex determination. They do this by regulating many cellular processes including cell proliferation, migration, polarity, apoptosis, differentiation and survival. Not unexpectedly, therefore, aberrations in Wnt signaling are now known to be involved in many diseases, including bone diseases, cancers, diabetes, neurodevelopment disorders, and several congenital malformations. In addition to the best known Wnt receptors (the Frizzleds), two additional Wnt receptor families have been identified: the Ryk family (Ryk in humans, Derailed, Derailed-2 and Doughnut in Drosophila) and the Ror family (Ror1 and Ror2 in human, DRor and DNrk in Drosophila). Both are receptor tyrosine kinase (RTK) families - a receptor class not typically associated with Wnt signaling, but a class that has been successfully targeted therapeutically in other signaling systems with kinase inhibitors and antibody therapeutics. The extracellular regions of Ryk and Ror family RTKs contain domains typically associated with binding to Wnt ligands. Ryks contain a Wnt Inhibitory Factor-1 (WIF) domain, and Rors contain an extracellular cysteine-rich domain (CRD) that resembles the Wnt-binding CRDs in the Frizzled receptors. We propose here to investigate the signaling mechanisms of Ryk and Ror family RTKs using an array of approaches from in vivo assays in Xenopus embryos and cellular studies to biochemical, biophysical and structural approaches. Our goal is to determine whether Ryk and Ror receptors resemble other well known RTKs in their mode of signaling, or instead function as co-receptors for Wnts with Frizzleds or other molecules. In our Specific Aims, we will address the following questions: 1. how do Ryk family members recognize their Wnt ligands, and do Ryks resemble other RTKs in their response to extracellular ligand binding? 2i. Do Ror family members resemble other RTKs in responses to ligand binding, and does Wnt binding by their cysteine-rich domains (CRDs) resemble that of Frizzleds? 2ii. Do Ryks and Rors heterodimerize, and can Wnts bind simultaneously to both WIF domains and CRDs to drive co-receptor heterodimerization? These studies will provide important fundamental new insight into how these novel classes of Wnt receptors signal, which is crucial for understanding Wnt signaling specificity and teasing out its multiple roles. In addition, our findings should open potential new avenues for therapeutic inhibition - as the roles of these Wnt-binding RTKs in disease become increasingly clear.
描述(由申请人提供):本提案的目的是了解两种在其胞外区具有Wnt结合结构域的受体酪氨酸激酶(RTK)如何介导和/或促进Wnt信号传导。Wnt是由大约330个氨基酸组成的分泌型配体,在胚胎发育中起关键作用,并控制成年人的一系列过程,从器官再生到干细胞维持,从神经回路生成到性别决定。它们通过调节许多细胞过程来实现这一点,包括细胞增殖、迁移、极性、凋亡、分化和存活。不出所料, 因此,现在已知Wnt信号传导中的异常与许多疾病有关,包括骨疾病、癌症、糖尿病、神经发育障碍和几种先天性畸形。除了最著名的Wnt受体(Frizzleds)外,还发现了另外两个Wnt受体家族:Ryk家族(人类的Ryk,果蝇的Derailed,Derailed-2和Doughnut)和Ror家族(人类的Ror 1和Ror 2,果蝇的DRor和DNrk)。两者都是受体酪氨酸激酶(RTK)家族-通常不与Wnt信号传导相关的受体类别,但已在其他信号传导系统中用激酶抑制剂和抗体治疗剂成功靶向治疗的类别。Ryk和Ror家族RTK的胞外区含有通常与结合Wnt配体相关的结构域。Ryks含有Wnt抑制因子-1(WIF)结构域,Rors含有细胞外富含半胱氨酸的结构域(CRD),类似于Frizzled受体中的Wnt结合CRD。 我们建议在这里调查Ryk和Ror家族RTK的信号转导机制,使用一系列的方法,从在非洲爪蟾胚胎和细胞研究的体内测定的生化,生物物理和结构的方法。我们的目标是确定Ryk和Ror受体在其信号传导模式上是否类似于其他众所周知的RTK,或者作为Wnt与Frizzleds或其他分子的共受体发挥作用。在我们的具体目标中,我们将解决以下问题:1。Ryk家族成员如何识别它们的Wnt配体,Ryk在对细胞外配体结合的反应中与其他RTK相似吗?2i. Ror家族成员在对配体结合的反应中是否类似于其他RTK,Wnt通过其富含半胱氨酸的结构域(CRD)的结合是否类似于Frizzleds?2二. Ryks和Rors异源二聚化吗?Wnt能否同时结合WIF结构域和CRD以驱动共受体异源二聚化?这些研究将为这些新型Wnt受体如何发出信号提供重要的基础性新见解,这对于理解Wnt信号传导特异性和梳理其多重作用至关重要。此外,我们的研究结果应该为治疗抑制开辟潜在的新途径-因为这些Wnt结合RTK在疾病中的作用越来越清楚。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mark A Lemmon其他文献

Mark A Lemmon的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mark A Lemmon', 18)}}的其他基金

Understanding how receptor tyrosine kinase activation dynamics specify proliferative cellular responses
了解受体酪氨酸激酶激活动力学如何指定增殖细胞反应
  • 批准号:
    10678825
  • 财政年份:
    2020
  • 资助金额:
    $ 53.21万
  • 项目类别:
Project 1: Improved Targeting of EGFR Family Members in Squamous Cell Carcinomas of the Head and Neck
项目 1:改进 EGFR 家族成员在头颈鳞状细胞癌中的靶向作用
  • 批准号:
    10668978
  • 财政年份:
    2020
  • 资助金额:
    $ 53.21万
  • 项目类别:
Understanding how receptor tyrosine kinase activation dynamics specify proliferative cellular responses
了解受体酪氨酸激酶激活动力学如何指定增殖细胞反应
  • 批准号:
    10263909
  • 财政年份:
    2020
  • 资助金额:
    $ 53.21万
  • 项目类别:
Project 1: Improved Targeting of EGFR Family Members in Squamous Cell Carcinomas of the Head and Neck
项目 1:改进 EGFR 家族成员在头颈鳞状细胞癌中的靶向作用
  • 批准号:
    10441508
  • 财政年份:
    2020
  • 资助金额:
    $ 53.21万
  • 项目类别:
Project 1: Improved Targeting of EGFR Family Members in Squamous Cell Carcinomas of the Head and Neck
项目 1:改进 EGFR 家族成员在头颈鳞状细胞癌中的靶向作用
  • 批准号:
    10267847
  • 财政年份:
    2020
  • 资助金额:
    $ 53.21万
  • 项目类别:
Understanding how receptor tyrosine kinase activation dynamics specify proliferative cellular responses
了解受体酪氨酸激酶激活动力学如何指定增殖细胞反应
  • 批准号:
    10400914
  • 财政年份:
    2020
  • 资助金额:
    $ 53.21万
  • 项目类别:
Understanding Signaling by Non-Canonical Receptor Tyrosine Kinases
了解非典型受体酪氨酸激酶的信号传导
  • 批准号:
    9914306
  • 财政年份:
    2017
  • 资助金额:
    $ 53.21万
  • 项目类别:
Understanding Signaling by Non-Canonical Receptor Tyrosine Kinases
了解非典型受体酪氨酸激酶的信号传导
  • 批准号:
    10598118
  • 财政年份:
    2017
  • 资助金额:
    $ 53.21万
  • 项目类别:
Understanding Signaling by Non-Canonical Receptor Tyrosine Kinases
了解非典型受体酪氨酸激酶的信号传导
  • 批准号:
    9275679
  • 财政年份:
    2017
  • 资助金额:
    $ 53.21万
  • 项目类别:
Understanding Signaling by Non-Canonical Receptor Tyrosine Kinases
了解非典型受体酪氨酸激酶的信号传导
  • 批准号:
    10406442
  • 财政年份:
    2017
  • 资助金额:
    $ 53.21万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.21万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 53.21万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 53.21万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 53.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 53.21万
  • 项目类别:
    Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 53.21万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 53.21万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 53.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 53.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 53.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了